BPMC
BLUEPRINT MEDICINES CORP
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$15.8M
Inst. Activity0 buys / 41 sells
SEC Reports1
Recent Activity
Jun 11, 2026
SEC
All five tracked mega-passive institutions (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley) entirely exited
INST-CLUSTER — Impact 7/10
Inst.
BARCLAYS PLC — NEAR_EXIT
171,196 shares ($15.8M)
Inst.
MORGAN STANLEY — EXIT
0 shares ($0.00)
Analyst Ratings
3Strong Buy
4Buy
18Hold
0Sell
0Strong Sell
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BARCLAYS PLC | $15.8M | NEAR_EXIT |
1 institutional holders with $15.8M total value (171,196 shares) as of 2025-Q3. Top holders: BARCLAYS. Net selling activity: 41 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BARCLAYS PLC | 171,196 | $15.8M | 100.0% | NEAR_EXIT -89.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BARCLAYS PLC | NEAR_EXIT | 1,556,918 | 171,196 | -89.0% | $15.8M | 2025-Q3 |
| MORGAN STANLEY | EXIT | 1,031,170 | 0 | -100.0% | $0.00 | 2025-Q3 |
| VANGUARD GROUP INC | EXIT | 6,416,603 | 0 | -100.0% | $0.00 | 2025-Q3 |
| BlackRock, Inc. | EXIT | 6,118,428 | 0 | -100.0% | $0.00 | 2025-Q3 |
| STATE STREET CORP | EXIT | 2,230,980 | 0 | -100.0% | $0.00 | 2025-Q3 |
| FMR LLC | EXIT | 558,960 | 0 | -100.0% | $0.00 | 2025-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | EXIT | 561,159 | 0 | -100.0% | $0.00 | 2025-Q3 |
| Invesco Ltd. | EXIT | 511,091 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | EXIT | 1,074,936 | 0 | -100.0% | $0.00 | 2025-Q3 |
| UBS Group AG | EXIT | 2,167,028 | 0 | -100.0% | $0.00 | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 674,500 | 0 | -100.0% | $0.00 | 2025-Q3 |
| SOROS FUND MANAGEMENT LLC | EXIT | 250,000 | 0 | -100.0% | $0.00 | 2025-Q3 |
| WELLINGTON MANAGEMENT GROUP LLP | EXIT | 435,976 | 0 | -100.0% | $0.00 | 2025-Q3 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | EXIT | 215,946 | 0 | -100.0% | $0.00 | 2025-Q3 |
| Legal & General Group Plc | EXIT | 99,224 | 0 | -100.0% | $0.00 | 2025-Q3 |
| FRANKLIN RESOURCES INC | EXIT | 173,510 | 0 | -100.0% | $0.00 | 2025-Q3 |
| Nuveen, LLC | EXIT | 488,612 | 0 | -100.0% | $0.00 | 2025-Q3 |
| TUDOR INVESTMENT CORP ET AL | EXIT | 468,623 | 0 | -100.0% | $0.00 | 2025-Q3 |
| LMR Partners LLP | EXIT | 395,857 | 0 | -100.0% | $0.00 | 2025-Q3 |
| STATE OF WISCONSIN INVESTMENT BOARD | EXIT | 89,373 | 0 | -100.0% | $0.00 | 2025-Q3 |
| JANUS HENDERSON GROUP PLC | EXIT | 268,928 | 0 | -100.0% | $0.00 | 2025-Q3 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | EXIT | 86,709 | 0 | -100.0% | $0.00 | 2025-Q3 |
| FIL Ltd | EXIT | 1,759,500 | 0 | -100.0% | $0.00 | 2025-Q3 |
| RHUMBLINE ADVISERS | EXIT | 99,649 | 0 | -100.0% | $0.00 | 2025-Q3 |
| Clearbridge Investments, LLC | EXIT | 405,708 | 0 | -100.0% | $0.00 | 2025-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 28% buy across 25 analysts — 3 strong buy, 4 buy, 18 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Nov 1, 2025 | 3 | 4 | 18 | 0 | 0 | 28% | |
| Oct 1, 2025 | 3 | 4 | 18 | 0 | 0 | 28% | |
| Sep 1, 2025 | 3 | 4 | 18 | 0 | 0 | 28% | |
| Aug 1, 2025 | 3 | 4 | 18 | 0 | 0 | 28% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.